The findings do not yet recommend vaccine mixing, but could pose challenges for the federal government, which is expected to decide whether to turn all vaccine boosters available by the end of the month into a green light. I have.
The Food and Drug Administration’s independent advisory board on vaccines voted this week on whether to recommend Moderna and J & J boosters, and the authorities are expected to make a decision shortly thereafter. The committee will also review the results of the mix-and-match study, but will not make any recommendations on the approach.
NIH studies have not yet been peer-reviewed. The authors acknowledged restrictions such as the majority of participants being Caucasian and the interval between an individual receiving the primary vaccine series and the booster being less than 6 months. This is the approved threshold for Pfizer-BioNTech Shot.
Linawen, an emergency physician and public health professor at George Washington University, said the results show that booster mixing and matching appear to be safe and effective.
Participated in J & J’s one-shot test and advocated the spread of boosters.
Last month’s FDA Permitted emergency use of Pfizer vaccine As a booster for people over the age of 65 and those at high risk of developing severe Covid due to health or work. A similar decision could be made for Moderna this week.
NIH Research: Moderna, Pfizer Shot is the Most Effective Covid Booster
Source link NIH Research: Moderna, Pfizer Shot is the Most Effective Covid Booster